Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002931.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 7.84 3.14 2.91
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -74.02 -65.85 253.52
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -2.52 3.78 3.87
Cash -7.47 1.29 1.40
Capex -71.83 -0.12 -0.07
Free Cash Flow 160.89 -0.18 0.07
Revenue -13.13 0.50 0.57
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 13.83 0.17 0.15
Operating Margin 49.71 -0.03 -0.07
ROA 67.05 < 0.005 -0.01
ROE 67.53 < 0.005 -0.02
ROIC 84.30 < 0.005 -0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002931.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002931.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002931.SZ is permitted for members.